| UniProt ID | SUZ12_HUMAN | |
|---|---|---|
| UniProt AC | Q15022 | |
| Protein Name | Polycomb protein SUZ12 | |
| Gene Name | SUZ12 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 739 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A.. | |
| Protein Sequence | MAPQKHGGGGGGGSGPSAGSGGGGFGGSAAVAAATASGGKSGGGSCGGGGSYSASSSSSAAAAAGAAVLPVKKPKMEHVQADHELFLQAFEKPTQIYRFLRTRNLIAPIFLHRTLTYMSHRNSRTNIKRKTFKVDDMLSKVEKMKGEQESHSLSAHLQLTFTGFFHKNDKPSPNSENEQNSVTLEVLLVKVCHKKRKDVSCPIRQVPTGKKQVPLNPDLNQTKPGNFPSLAVSSNEFEPSNSHMVKSYSLLFRVTRPGRREFNGMINGETNENIDVNEELPARRKRNREDGEKTFVAQMTVFDKNRRLQLLDGEYEVAMQEMEECPISKKRATWETILDGKRLPPFETFSQGPTLQFTLRWTGETNDKSTAPIAKPLATRNSESLHQENKPGSVKPTQTIAVKESLTTDLQTRKEKDTPNENRQKLRIFYQFLYNNNTRQQTEARDDLHCPWCTLNCRKLYSLLKHLKLCHSRFIFNYVYHPKGARIDVSINECYDGSYAGNPQDIHRQPGFAFSRNGPVKRTPITHILVCRPKRTKASMSEFLESEDGEVEQQRTYSSGHNRLYFHSDTCLPLRPQEMEVDSEDEKDPEWLREKTITQIEEFSDVNEGEKEVMKLWNLHVMKHGFIADNQMNHACMLFVENYGQKIIKKNLCRNFMLHLVSMHDFNLISIMSIDKAVTKLREMQQKLEKGESASPANEEITEEQNGTANGFSEINSKEKALETDSVSGVSKQSKKQKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Methylation | ---MAPQKHGGGGGG ---CCCCCCCCCCCC | 43.06 | 115980289 | |
| 14 | Phosphorylation | GGGGGGGSGPSAGSG CCCCCCCCCCCCCCC | 51.29 | 23186163 | |
| 17 | Phosphorylation | GGGGSGPSAGSGGGG CCCCCCCCCCCCCCC | 49.11 | 25159151 | |
| 20 | Phosphorylation | GSGPSAGSGGGGFGG CCCCCCCCCCCCCCH | 33.70 | 23917254 | |
| 35 | Phosphorylation | SAAVAAATASGGKSG HHHHHHHHCCCCCCC | 19.34 | 25850435 | |
| 37 | Phosphorylation | AVAAATASGGKSGGG HHHHHHCCCCCCCCC | 43.66 | 25159151 | |
| 72 | Sumoylation | GAAVLPVKKPKMEHV CCEEEECCCCCCCCC | 62.51 | - | |
| 72 | Sumoylation | GAAVLPVKKPKMEHV CCEEEECCCCCCCCC | 62.51 | 18628979 | |
| 73 | Sumoylation | AAVLPVKKPKMEHVQ CEEEECCCCCCCCCC | 50.53 | - | |
| 73 | Sumoylation | AAVLPVKKPKMEHVQ CEEEECCCCCCCCCC | 50.53 | 18628979 | |
| 75 | Sumoylation | VLPVKKPKMEHVQAD EEECCCCCCCCCCCC | 66.84 | 18628979 | |
| 75 | Sumoylation | VLPVKKPKMEHVQAD EEECCCCCCCCCCCC | 66.84 | - | |
| 92 | Ubiquitination | LFLQAFEKPTQIYRF HHHHHHCCHHHHHHH | 47.08 | - | |
| 131 | Phosphorylation | RTNIKRKTFKVDDML CCCCCCCEEEHHHHH | 32.49 | 16674116 | |
| 139 | Phosphorylation | FKVDDMLSKVEKMKG EEHHHHHHHHHHHCC | 28.19 | 16674116 | |
| 140 | Sumoylation | KVDDMLSKVEKMKGE EHHHHHHHHHHHCCC | 50.91 | - | |
| 140 | Sumoylation | KVDDMLSKVEKMKGE EHHHHHHHHHHHCCC | 50.91 | - | |
| 140 | Acetylation | KVDDMLSKVEKMKGE EHHHHHHHHHHHCCC | 50.91 | 19812019 | |
| 143 | Acetylation | DMLSKVEKMKGEQES HHHHHHHHHCCCCHH | 49.23 | 19812027 | |
| 145 | Acetylation | LSKVEKMKGEQESHS HHHHHHHCCCCHHCC | 71.07 | 19812035 | |
| 170 | Acetylation | GFFHKNDKPSPNSEN ECCCCCCCCCCCCCC | 57.71 | 25953088 | |
| 172 | Phosphorylation | FHKNDKPSPNSENEQ CCCCCCCCCCCCCCC | 42.32 | 30576142 | |
| 197 | Ubiquitination | KVCHKKRKDVSCPIR HHHHHCCCCCCCCCC | 71.95 | - | |
| 223 | Acetylation | NPDLNQTKPGNFPSL CCCCCCCCCCCCCCE | 40.96 | 26051181 | |
| 223 | Sumoylation | NPDLNQTKPGNFPSL CCCCCCCCCCCCCCE | 40.96 | 28112733 | |
| 223 | Ubiquitination | NPDLNQTKPGNFPSL CCCCCCCCCCCCCCE | 40.96 | - | |
| 240 | Phosphorylation | SSNEFEPSNSHMVKS ECCCCCCCCCHHCEE | 43.71 | 25627689 | |
| 246 | Acetylation | PSNSHMVKSYSLLFR CCCCHHCEEEEEEEE | 35.78 | 25953088 | |
| 248 | Phosphorylation | NSHMVKSYSLLFRVT CCHHCEEEEEEEEEC | 9.53 | 24719451 | |
| 255 | Phosphorylation | YSLLFRVTRPGRREF EEEEEEECCCCCCCC | 27.22 | 24719451 | |
| 293 | Acetylation | RNREDGEKTFVAQMT HCCCCCCEEEEEEEE | 53.44 | 25953088 | |
| 328 | Phosphorylation | EMEECPISKKRATWE HHHHCCCCCCCCCHH | 19.78 | 30576142 | |
| 336 | Phosphorylation | KKRATWETILDGKRL CCCCCHHHHHCCCCC | 20.57 | - | |
| 341 | Ubiquitination | WETILDGKRLPPFET HHHHHCCCCCCCCCC | 50.89 | 21890473 | |
| 341 | Acetylation | WETILDGKRLPPFET HHHHHCCCCCCCCCC | 50.89 | 25953088 | |
| 358 | Phosphorylation | QGPTLQFTLRWTGET CCCEEEEEEEEECCC | 11.49 | 24719451 | |
| 368 | Ubiquitination | WTGETNDKSTAPIAK EECCCCCCCCCCCCC | 52.34 | 21890473 | |
| 375 | Ubiquitination | KSTAPIAKPLATRNS CCCCCCCCCCCCCCC | 41.08 | 21890473 | |
| 375 | Acetylation | KSTAPIAKPLATRNS CCCCCCCCCCCCCCC | 41.08 | 25953088 | |
| 379 | Phosphorylation | PIAKPLATRNSESLH CCCCCCCCCCCHHHC | 37.76 | 25159151 | |
| 382 | Phosphorylation | KPLATRNSESLHQEN CCCCCCCCHHHCCCC | 25.85 | 23663014 | |
| 384 | Phosphorylation | LATRNSESLHQENKP CCCCCCHHHCCCCCC | 30.85 | 23663014 | |
| 390 | Sumoylation | ESLHQENKPGSVKPT HHHCCCCCCCCCCCC | 50.43 | 28112733 | |
| 390 | Ubiquitination | ESLHQENKPGSVKPT HHHCCCCCCCCCCCC | 50.43 | - | |
| 393 | Phosphorylation | HQENKPGSVKPTQTI CCCCCCCCCCCCCEE | 35.18 | 23917254 | |
| 395 | Ubiquitination | ENKPGSVKPTQTIAV CCCCCCCCCCCEEEE | 44.00 | - | |
| 397 | Phosphorylation | KPGSVKPTQTIAVKE CCCCCCCCCEEEEEE | 32.40 | 23186163 | |
| 399 | Phosphorylation | GSVKPTQTIAVKESL CCCCCCCEEEEEEEH | 17.24 | 23186163 | |
| 403 | Methylation | PTQTIAVKESLTTDL CCCEEEEEEEHHHCH | 32.34 | 24129315 | |
| 405 | Phosphorylation | QTIAVKESLTTDLQT CEEEEEEEHHHCHHH | 25.87 | 22210691 | |
| 407 | Phosphorylation | IAVKESLTTDLQTRK EEEEEEHHHCHHHHH | 27.78 | 22210691 | |
| 412 | Phosphorylation | SLTTDLQTRKEKDTP EHHHCHHHHHHCCCC | 51.51 | - | |
| 414 | Methylation | TTDLQTRKEKDTPNE HHCHHHHHHCCCCCH | 72.93 | 116252705 | |
| 418 | Phosphorylation | QTRKEKDTPNENRQK HHHHHCCCCCHHHHH | 38.80 | 30576142 | |
| 430 | Phosphorylation | RQKLRIFYQFLYNNN HHHHHHHHHHHHCCC | 8.93 | 24043423 | |
| 434 | Phosphorylation | RIFYQFLYNNNTRQQ HHHHHHHHCCCCCCC | 19.68 | 24043423 | |
| 438 | Phosphorylation | QFLYNNNTRQQTEAR HHHHCCCCCCCCCCC | 31.79 | 24043423 | |
| 461 | Phosphorylation | TLNCRKLYSLLKHLK HHHHHHHHHHHHHHH | 10.58 | 24719451 | |
| 462 | Phosphorylation | LNCRKLYSLLKHLKL HHHHHHHHHHHHHHH | 37.35 | 24719451 | |
| 465 | Acetylation | RKLYSLLKHLKLCHS HHHHHHHHHHHHHHH | 52.78 | 26051181 | |
| 478 | Phosphorylation | HSRFIFNYVYHPKGA HHHHHEEECCCCCCC | 7.52 | 23663014 | |
| 480 | Phosphorylation | RFIFNYVYHPKGARI HHHEEECCCCCCCEE | 11.31 | 23663014 | |
| 483 | Acetylation | FNYVYHPKGARIDVS EEECCCCCCCEEEEE | 52.47 | 25953088 | |
| 537 | Ubiquitination | VCRPKRTKASMSEFL EECCCCCCCHHHHHH | 42.36 | 21890473 | |
| 539 | Phosphorylation | RPKRTKASMSEFLES CCCCCCCHHHHHHHC | 25.13 | 30266825 | |
| 541 | Phosphorylation | KRTKASMSEFLESED CCCCCHHHHHHHCCC | 23.77 | 30266825 | |
| 546 | Phosphorylation | SMSEFLESEDGEVEQ HHHHHHHCCCCCEEE | 43.04 | 29255136 | |
| 565 | Phosphorylation | SSGHNRLYFHSDTCL CCCCCEEEEECCCEE | 8.94 | 24732914 | |
| 568 | Phosphorylation | HNRLYFHSDTCLPLR CCEEEEECCCEEECC | 25.39 | 23898821 | |
| 570 | Phosphorylation | RLYFHSDTCLPLRPQ EEEEECCCEEECCCC | 20.96 | 23898821 | |
| 583 | Phosphorylation | PQEMEVDSEDEKDPE CCCCCCCCCCCCCHH | 52.72 | 25159151 | |
| 595 | Ubiquitination | DPEWLREKTITQIEE CHHHHHHHHEEEEHH | 38.50 | - | |
| 604 | Phosphorylation | ITQIEEFSDVNEGEK EEEEHHHCCCCHHHH | 43.88 | - | |
| 687 | Ubiquitination | KLREMQQKLEKGESA HHHHHHHHHHCCCCC | 41.54 | - | |
| 693 | Phosphorylation | QKLEKGESASPANEE HHHHCCCCCCCCCHH | 42.59 | 30266825 | |
| 695 | Phosphorylation | LEKGESASPANEEIT HHCCCCCCCCCHHCC | 33.55 | 23401153 | |
| 702 | Phosphorylation | SPANEEITEEQNGTA CCCCHHCCHHHCCCC | 36.43 | 30266825 | |
| 708 | Phosphorylation | ITEEQNGTANGFSEI CCHHHCCCCCCCHHC | 25.21 | 30266825 | |
| 713 | Phosphorylation | NGTANGFSEINSKEK CCCCCCCHHCCCCCH | 38.68 | 29978859 | |
| 724 | Phosphorylation | SKEKALETDSVSGVS CCCHHHHCCCCCCCC | 34.13 | 29255136 | |
| 726 | Phosphorylation | EKALETDSVSGVSKQ CHHHHCCCCCCCCHH | 26.13 | 23401153 | |
| 728 | Phosphorylation | ALETDSVSGVSKQSK HHHCCCCCCCCHHHH | 37.11 | 25262027 | |
| 731 | Phosphorylation | TDSVSGVSKQSKKQK CCCCCCCCHHHHHCC | 28.62 | 30108239 | |
| 732 | Acetylation | DSVSGVSKQSKKQKL CCCCCCCHHHHHCCC | 57.07 | 25953088 | |
| 734 | Phosphorylation | VSGVSKQSKKQKL-- CCCCCHHHHHCCC-- | 45.62 | 20873877 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 539 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 541 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 546 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | PJA1 | Q8NG27 | PMID:21513699 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SUZ12_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SUZ12_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546 AND SER-583, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546 AND SER-583, ANDMASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-726, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-418, AND MASSSPECTROMETRY. | |
| Sumoylation | |
| Reference | PubMed |
| "The polycomb repressive complex 2 is a potential target of SUMOmodifications."; Riising E.M., Boggio R., Chiocca S., Helin K., Pasini D.; PLoS ONE 3:E2704-E2704(2008). Cited for: SUMOYLATION AT LYS-72; LYS-73 AND LYS-75. | |